Fahar Merchant, Chairman, President & Chief Executive Officer at Medicenna Therapeutics Corp, holds 5.84M shares in Medicenna Therapeutics Corp (Ticker: TSE:MDNA). Most recently, Fahar Merchant Bought 32,000 shares of Medicenna Therapeutics Corp on Dec 16, 2025 for an estimated value of C$35.52K.
What is the percentage of profitable transactions made by Fahar Merchant?
The percentage of profitable transactions made by Fahar Merchant is 33%.
What is the average return per transaction made by Fahar Merchant?
The average return per transaction made by Fahar Merchant is 8.80%.
What stocks does Fahar Merchant hold?
Fahar Merchant holds: TSE:MDNA stocks.
What was Fahar Merchant’s latest transaction?
Fahar Merchant latest transaction was an Informative Buy of C$35.52K.
What was Fahar Merchant's most profitable transaction?
Fahar Merchant’s most profitable transaction was an Informative Buy of TSE:MDNA stock on December 24, 2018. The return on the trade was 289.10%.
What is Fahar Merchant's role in Medicenna Therapeutics Corp?
Fahar Merchant's role in Medicenna Therapeutics Corp is Chairman, President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.